)
Edge6 Mar 2026
Upvoted: The Story of Reddit
How Reddit built a unique platform around communities and conversation, turning human insight and intent into a distinctive business model.
PolyPeptide Group
PolyPeptide Group (PPGN) investor relations material
PolyPeptide Group H2 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.H2 2025 earnings summary12 Mar, 2026
Executive summary
Achieved 16% revenue growth at constant exchange rates in 2025, reaching EUR 389.3 million, mainly driven by metabolic therapeutics and strong customer demand.
EBITDA margin improved from 7.5% in 2024 to 12% in 2025, with EBITDA of EUR 46.8 million (+84.4%).
Operating result (EBIT) turned positive at EUR 8.7 million from a loss of EUR -7.4 million in 2024.
Strong operating cash flow and customer prepayments expanded financing flexibility and supported accelerated investments; no equity raise planned.
Commercial revenue rose to 61% of total, with large pharma as the main growth driver.
Financial highlights
2025 sales reached EUR 389.3 million, up 16% at constant exchange rates.
Development business grew nearly 30% to EUR 153 million; commercial business up 7.9% to EUR 236 million.
EBITDA improved by over EUR 40 million, reaching EUR 46.8 million (12% margin); H2 margin at 19%.
Net result for 2025 was -EUR 21.2 million, impacted by unrealized FX losses and IFRS contract liability treatment.
Operating cash flow was EUR 77.5 million, with year-end cash at EUR 74.6 million.
Outlook and guidance
2026 revenue growth expected at 20%-25% at constant exchange rates.
EBITDA margin targeted at mid to high teens for 2026, supported by full-year Braine-l'Alleud contribution.
CapEx for 2026 guided at 15%-20% of revenues, in line with midterm outlook.
2028 midterm guidance confirmed, targeting EBITDA margin approaching 25% and doubling 2023 revenue.
No dividend proposed for 2026 as investments continue.
Belgium SPPS asset revenue potential increase
Strategic shift from oncology to metabolics
Sustainability of customer-funded capex model
Braine-l'Alleud revenue potential optimization
Update on RCF expansion and customer prepayments
Commercial conversion of Phase III metabolics
Braine-l'Alleud output optimization impact?
PolyPeptide's strategy for generic peptides?
Funding strategy for post-2028 capacity?
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Next PolyPeptide Group earnings date
H1 202613 Aug, 2026
PolyPeptide Group
Next PolyPeptide Group earnings date
H1 202613 Aug, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
PolyPeptide Group AG is a leading contract development and manufacturing organization (CDMO) specializing in the production of peptides and related molecules. The company provides services across the entire development spectrum, from initial peptide synthesis to commercial-scale manufacturing. PolyPeptide supports pharmaceutical and biotech companies with both proprietary and generic Good Manufacturing Practice (GMP)-grade peptides used in approved pharmaceutical products, drugs in clinical development, and in generic products. Additionally, it manufactures a variety of peptides used in cosmetic applications. The company is headquartered in Baar, Canton of Zug, Switzerland, and its shares are listed on the stock exchange.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage